...
首页> 外文期刊>The biochemical journal >Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins
【24h】

Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins

机译:瓦普林(一种蛇毒蛋白的瓦普林家族的新成员)的抗菌活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pWe have isolated and characterized omwaprin, a 50-amino-acid cationic protein from the venom of inland taipan (iOxyuranus microlepidotus/i). It is a new member of the waprin family of snake venom proteins. A synthetic gene was designed and constructed for expressing the recombinant protein in iEscherichia coli/i. Recombinant omwaprin was used for carrying out functional analyses. The protein is non-toxic to Swiss albino mice at doses of up to 10 mg/kg when administered intraperitoneally. However, it shows selective and dose-dependant antibacterial activity against Gram-positive bacteria. The minimum inhibitory doses were in the range 2–10 μg for selected species of bacteria in radial diffusion assays. The antibacterial activity is salt-tolerant up to 350 mM NaCl. However, omwaprin lost its antibacterial activity upon reduction and alkylation of its cysteine residues, or upon deletion of six N-terminal amino acid residues, four of which are positively charged. These observations indicate that the three-dimensional structure constrained by four disulfide bonds and the N-terminal residues are essential for its activity. The mechanism of action is via membrane disruption, as shown by scanning electron microscopy. Importantly, omwaprin lacks haemolytic activity on human erythrocytes. This demonstrates the specificity of omwaprin for bacterial membranes. Unlike other reported WAP (whey acidic protein) domain-containing antibacterial proteins, including elafin, EPPIN (epididymal proteinase inhibitor), SWAM1 and SWAM2 [single WAP (whey acidic protein) motif proteins 1 and 2] and SLPI (secretory leucocyte proteinase inhibitor), omwaprin shows species-specific activity on the Gram-positive bacteria tested./p
机译:>我们已经从内陆大班毒液(Oxyuranus microlepidotus )的毒液中分离并鉴定了50个氨基酸的阳离子蛋白omwaprin。它是蛇毒蛋白的瓦普林家族的新成员。设计并构建了一个用于在大肠杆菌中表达重组蛋白的合成基因。重组omwaprin用于进行功能分析。腹膜内给药时,该蛋白对瑞士白化病小鼠无毒,剂量最高为10 mg / kg。但是,它显示出对革兰氏阳性细菌的选择性和剂量依赖性抗菌活性。在径向扩散测定中,所选细菌的最小抑制剂量范围为2–10μg。抗菌活性最高可达350 mM NaCl。但是,omwaprin在其半胱氨酸残基还原和烷基化后,或在缺失六个N端氨基酸残基(其中四个带有正电荷)时失去了其抗菌活性。这些观察表明,由四个二硫键和N端残基约束的三维结构对其活性至关重要。作用机理是通过膜破坏,如扫描电子显微镜所示。重要的是,omwaprin对人的红血球缺乏溶血活性。这证明了omwaprin对细菌膜的特异性。与其他报道的WAP(含乳清蛋白)结构域的抗菌蛋白不同,包括elafin,EPPIN(附睾蛋白酶抑制剂),SWAM1和SWAM2 [单个WAP(乳清蛋白)基序蛋白1和2]和SLPI(分泌型白细胞蛋白酶抑制剂) omwaprin对测试的革兰氏阳性细菌显示出物种特异性活性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号